George Vlasuk/X
Nov 6, 2026, 04:28
George Vlasuk: A New LMWH Without the Risk of HIT?
George Vlasuk, Technical Consultant at Navitor Pharmaceuticals, shared a post on X about a recent article by Jian-Qun Deng et al., published in Science Translational Medicine, adding:
“Really, a new LMWH? – A synthetic heparin oligosaccharide decouples anticoagulation from heparin-induced thrombocytopenia risk.”
Title: A synthetic heparin oligosaccharide decouples anticoagulation from heparin-induced thrombocytopenia risk
Authors: Jian-Qun Deng, Xian-Xian Duan, Yu-Han Zhao, Yi Li, Ya-Lin Cao, Xin-Yu Li, Chao-Yue Li, Wen-Jie Jiang, Feng Xu, Ju-Zheng Sheng
Stay updated with Hemostasis Today.
-
Nov 6, 2026, 10:29Luisa Weiss: How Platelets Drive Inflammation in Aortic Valve Disease
-
Nov 6, 2026, 10:18Dave Cartland: A Rare Case of Portal Vein Thrombosis After Moderna Vaccination
-
Nov 6, 2026, 10:10Iván Camilo Triana Avellaneda: Uncovering Distinct Clinical Phenotypes of DVT
-
Nov 6, 2026, 10:06Rafael Zubirán: Lp(a) – The Missing Link Between Inflammation and Thrombosis
-
Nov 6, 2026, 09:59Syeda Jazilah Faisal: Upstream Heparin in STEMI – Improving Coronary Reperfusion Before PCI
-
Nov 6, 2026, 09:51N. Mariana S. Vasquez: Understanding the 3 Main Types of Leg Ulcers
-
Nov 6, 2026, 08:22How Bleeding Disorders Affect Social Life and Well-Being? – EHC
-
Nov 6, 2026, 08:13Jared Rice: Why Neonatal Coagulation Cannot Be Interpreted Like Adult Coagulation
-
Nov 6, 2026, 08:07Matthew Smeds: Endovascular Salvage of Acute IVC Thrombosis After Liver Transplantation